0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
  • PAREA Events,
• 18/05/2026

Psychedelic Research & Access in Ukraine | European Parliament, May 6, 2026

How could evidence-based psychedelic therapies help address war-related mental health challenges in Ukraine, particularly PTSD among veterans? This was the main question of the European Parliament event held on 6 May, which Drugreporter captured on video in its entirety.

Previous

PAREA is Translating Psychedelic Science Evidence to Policy at the EU Level – Tadeusz Hawrot

Next

Addressing psychological distress in palliative care; the EU funded PsyPal project on psychedelic therapy | EUHPP webinar

You Might Also Like

Related Embedded Video Item Thumbnail SA TAIP seminar | Tadeusz Hawrot - "Psychedelic advances in the EU"
Related Embedded Video Item Thumbnail Testimonial of Lauren Macdonald, cancer patient, delivered at the PsyPal launch event
Related Embedded Video Item Thumbnail From Lagging to Leading: Mental Health Innovation "Made in Europe" | Norrsken House Brussels
Related Embedded Video Item Thumbnail Dave Pounds - MDMA for Alcohol Use Disorder
Related Embedded Video Item Thumbnail Launch of the PsychedeliCare and MEP Action Group on Psychedelics in Healthcare at the European Parliament 06.02.2025

Our Work

About
Why

Contact

tadeusz@parea.eu

© Parea 2024 | Privacy Policy